These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6228452)

  • 21. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
    Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
    Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers.
    Poovorawan Y; Chongsrisawat V; Theamboonlers A; Srinivasa K; Hutagalung Y; Bock HL; Hoet B
    J Infect Dis; 2009 Jul; 200(1):33-8. PubMed ID: 19473096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B vaccine: simultaneous passive and active immunization. Indications in pre- and post-exposure.
    Goudeau A; Dubois F; Geslin N; Pierre D
    Dev Biol Stand; 1983; 54():259-66. PubMed ID: 6228467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen.
    Stephan W; Prince AM; Brotman B
    J Virol; 1984 Aug; 51(2):420-4. PubMed ID: 6748163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparing immunogenicity and efficacy of two hepatitis B vaccines in newborn infants of hepatitis B surface antigen (+)/hepatitis B e antigen (+) carrier mothers].
    Liu Y; Liu X; Kuang J
    Zhonghua Fu Chan Ke Za Zhi; 1999 Aug; 34(8):470-2. PubMed ID: 11360596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay.
    Tuaillon E; Tabaa YA; Petitjean G; Huguet MF; Pajeaux G; Fondere JM; Ponseille B; Ducos J; Blanc P; Vendrell JP
    J Immunol Methods; 2006 Aug; 315(1-2):144-52. PubMed ID: 16959261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
    Zhou Z; Chen WS; Zhang HH; Yao JL
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
    Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
    J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of hepatitis B infection within family contacts of chronic liver disease patients--does HBeAg positivity really matter?
    Thakur V; Guptan RC; Malhotra V; Basir SF; Sarin SK
    J Assoc Physicians India; 2002 Nov; 50():1386-94. PubMed ID: 12583467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The detection of serum hepatitis B virus Pre-S1 antigen and its relationship with HBeAg/anti-HBe and HBV DNA by polymerase chain reaction].
    Xu B; Yao G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):117-20. PubMed ID: 15619813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization.
    Hipgrave DB; Nguyen TV; Vu MH; Hoang TL; Do TD; Tran NT; Jolley D; Maynard JE; Biggs BA
    Am J Trop Med Hyg; 2003 Sep; 69(3):288-94. PubMed ID: 14628946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and potency aspects in the preparation of an experimental HBsAg vaccine.
    Thomssen R; Gerlich WH; Böttcher U; Legler K; Ritter S; Stibbe W; Weinmann W; Klinge O; Pfeifer U
    Dev Biol Stand; 1983; 54():23-31. PubMed ID: 6228464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.